✦ LIBER ✦

Vascular effects of aromatase inhibitors: Data from clinical trials

✍ Scribed by Anthony Howell; Jack Cuzick

Book ID: 116697611
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 89 KB
Volume: 95
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2005.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Vascular effects of arom

Corrigendum to “Vascular effects of aromatase inhibitors: Data from clinical trials” [J. Steroid Biochem. Mol. Biol. 95 (2005) 143–149]

✍ Anthony Howell; Jack Cuzick 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Treatment of vascular dementia—evidence

Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors

✍ Timo Erkinjuntti; Gustavo Román; Serge Gauthier 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Effects of adjuvant aromatase inhibitors

Effects of adjuvant aromatase inhibitors on bone mineral density -observations from clinical practice

✍ S. Hopkins; S. Dent; S. Verma 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Biological and clinical effects of aroma

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy

✍ W.R Miller; J.M Dixon; D.A Cameron; T.J Anderson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Storage of data from clinical trials

✍ PhilipM.W. Bath; Peter Sandercock; Carl Counsell 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 160 KB

Summary of aromatase inhibitor clinical

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge